Related references
Note: Only part of the references are listed.Blood-based redox-signature and their association to the cognitive scores in MCI and Alzheimer's disease patients
Morgane Perrotte et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
A novel cell-cell communication mechanism in the nervous system: exosomes
Guan Zhang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2018)
Exosomes as possible spread factor and potential biomarkers in Alzheimer's disease: current concepts
Ryszard Pluta et al.
BIOMARKERS IN MEDICINE (2018)
Glycation Damage: A Possible Hub for Major Pathophysiological Disorders and Aging
Maxime Fournet et al.
AGING AND DISEASE (2018)
Current state of Alzheimer's fluid biomarkers
Jose Luis Molinuevo et al.
ACTA NEUROPATHOLOGICA (2018)
Exosomes as Carriers of Alzheimer's Amyloid-β
Kohei Yuyama et al.
FRONTIERS IN NEUROSCIENCE (2017)
The role of extracellular vesicles in neurodegenerative diseases
Camelia Quek et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Role of RAGE in Alzheimer's Disease
Zhiyou Cai et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2016)
Exosomes as new diagnostic tools in CNS diseases
Katja M. Kanninen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Plasma Levels of Pentosidine, Carboxymethyl-Lysine, Soluble Receptor for Advanced Glycation End Products, and Metabolic Syndrome: The Metformin Effect
Mohamed Haddad et al.
DISEASE MARKERS (2016)
Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients
Fabio Di Domenico et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Exosomes in Alzheimer's disease
Tarja Malm et al.
NEUROCHEMISTRY INTERNATIONAL (2016)
Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study
Massimo S. Fiandaca et al.
ALZHEIMERS & DEMENTIA (2015)
Protein glycation - Between tissue aging and protection
Andreas Simm et al.
EXPERIMENTAL GERONTOLOGY (2015)
An optimized procedure for exosome isolation and analysis using serum samples: Application to cancer biomarker discovery
Mu Li et al.
METHODS (2015)
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Hirohide Asai et al.
NATURE NEUROSCIENCE (2015)
Amnestic Mild Cognitive Impairment and Conversion to Alzheimer's Disease: Insulin Resistance and Glycoxidation as Early Biomarker Clusters
Fiammetta Monacelli et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
Kerstin Nowotny et al.
BIOMOLECULES (2015)
Pentosidine determination in CSF: a potential biomarker of Alzheimer's disease?
Fiammetta Monacelli et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
Pathogenesis of Alzheimer Disease: Role of Oxidative Stress, Amyloid-β Peptides, Systemic Ammonia and Erythrocyte Energy Metabolism
Elena A. Kosenko et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
Aβ-AGE AGGRAVATES COGNITIVE DEFICIT IN RATS VIA RAGE PATHWAY
C. Chen et al.
NEUROSCIENCE (2014)
Effect of advanced glycation end product intake on inflammation and aging: a systematic review
Katrien Van Puyvelde et al.
NUTRITION REVIEWS (2014)
Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients
Mohsen Kerkeni et al.
DIABETES & VASCULAR DISEASE RESEARCH (2013)
Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation
G. Vistoli et al.
FREE RADICAL RESEARCH (2013)
Protein glycation during aging and in cardiovascular disease
Andreas Simm
JOURNAL OF PROTEOMICS (2013)
Oxidative Stress and the Pathogenesis of Alzheimer's Disease
Yan Zhao et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Serum Levels of Advanced Glycation End Products (AGEs) are Independent Correlates of Insulin Resistance in Nondiabetic Subjects
Nobuhiro Tahara et al.
CARDIOVASCULAR THERAPEUTICS (2012)
Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia
M. C. Puertas et al.
EXPERIMENTAL GERONTOLOGY (2012)
Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease
Sudad Saman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Exosomal cell-to-cell transmission of alpha synuclein oligomers
Karin M. Danzer et al.
MOLECULAR NEURODEGENERATION (2012)
AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation
Xiao-Hong Li et al.
NEUROBIOLOGY OF AGING (2012)
New Criteria for Alzheimer Disease and Mild Cognitive Impairment Implications for the Practicing Clinician
Andrew E. Budson et al.
NEUROLOGIST (2012)
Circulating biomarkers of protein oxidation for Alzheimer disease: Expectations within limits
Fabio Di Domenico et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2011)
Differences in glyoxal and methylglyoxal metabolism determine cellular susceptibility to protein carbonylation and cytotoxicity
Kai Yang et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2011)
RAGE biology, atherosclerosis and diabetes
Drazenka Pongrac Barlovic et al.
CLINICAL SCIENCE (2011)
Serum advanced glycation end products (AGEs) are associated with insulin resistance
Kathryn C. B. Tan et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Involvement of Toxic AGEs (TAGE) in the Pathogenesis of Diabetic Vascular Complications and Alzheimer's Disease
Masayoshi Takeuchi et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Dissociation of functional status from accrual of CML and RAGE in the aged mouse brain
Nopporn Thangthaeng et al.
EXPERIMENTAL GERONTOLOGY (2008)
Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease
J. Greilberger et al.
FREE RADICAL RESEARCH (2008)
Circulating glycotoxins and dietary advanced glycation endproducts: Two links to inflammatory response, oxidative stress, and aging
Jaime Uribarri et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2007)
The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment
ZS Nasreddine et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains
HJ Lüth et al.
CEREBRAL CORTEX (2005)
Neurodegenerative diseases and oxidative stress
KJ Barnham et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Histochemical accumulation of oxidative damage products is associated with Alzheimer-like pathology in the canine
JE Rofina et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2004)
Nε-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease
X Gironés et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Pentosidine and Nε-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia
KJ Bär et al.
NEUROBIOLOGY OF AGING (2003)
Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry
PJ Thornalley et al.
BIOCHEMICAL JOURNAL (2003)
Accumulation of imidazolone, pentosidine and Nε-(carboxymethyl)lysine in hippocampal CA4 pyramidal neurons of aged human brain
T Jono et al.
PATHOLOGY INTERNATIONAL (2002)
Serum pentosidine as an indicator of Alzheimer's disease
M. Meli et al.
JOURNAL OF ALZHEIMERS DISEASE (2002)
Serum cleaved Tau protein and neurobehavioral battery of tests as markers of brain injury in experimental bacterial meningitis
JE Irazuzta et al.
BRAIN RESEARCH (2001)
Active glycation in neurofibrillary pathology of Alzheimer disease:: Nε-(carboxymethyl) lysine and hexitol-lysine
RJ Castellani et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Transition metal-mediated glycoxidation accelerates cross-linking of β-amyloid peptide
C Loske et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
